Phase II study of fludarabine, cytarabine (ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders
Apostolia M. Tsimberidou, Susan M. O'Brien, Jorge E. Cortes, Stefan Faderl, Michael Andreeff, Hagop M. Kantarjian, Michael J. Keating, Francis J. Giles
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase II study of fludarabine, cytarabine (ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders'. Together they form a unique fingerprint.